Mesothelioma information

In almost all cases, a person who has been diagnosed with mesothelioma has the right to recover compensation. The spouse of the perosn diagnosed also has a claim for injuries. If a person diagnosed with mesothelioma has died, his wife, children or disignated person from the will have the right to file a mesothelioma against asbestos manufacturers.

Limitations

If you have diagnosed with mesothelioma or if a loved one diagnosed with mesothelioma is decreased your case must be filed within the stateute of limitations. A statute of limitations is the time by which a person must file a lawsuit after a claim arises. If a lawsuit is not filed by that date the person will forever be barred from seeking compensation for their injured. Each state has it own statute of limitations for filing a lawsuit in most cases, the statute of limitations for filing a mesothelioma lawsuit is one or two years from the date a person is diagnosed with the disease or in the case of a wrongful death, the date that a person died of mesothelium its very important to contact one of mesothelioma lawers before the statute of limitations passes.

After one of your mesothelioma lawyere has identified the asbestos companies, your mesothelioma law firm will file a lawsuit naming these companies as defendants. Your case will not be filed as a class action. It will be filed as an individual mesothelioma lawsuit.

In the United Kingdom, the Medical Boarding Centre (Respiratory Disease) evaluates claims in relation to possible asbestos- related lung disease. This includes Mesothelioma and the Medical Boarding Centre can award compensation if, on the balance of probabilities, a Mesothelioma is felt to be present, even in the absence of a definite histological diagnosis. Similar arrangements are present in many other industrialized countries. Alternatively, patients may take out a legal action against their previous employers on the basis that they failed to provide adequate protection from exposure to asbestos. Such actions may be successful irrespective of a successful application to the Medical Boarding Centre.

Treatment can be done in three kinds they are:

Surgery
Radiotherapy
Chemotherapy



Role of surgery in Mesothelioma

Surgery has a very limited role because the patients usually present late, by which time there is often widespread pleural involvement. Very few patients can therefore be considered for surgical interaction.

There are two possible procedures. The first is a combined pneumonectomy and pleuro-percardectomy. This is a major operation which is only possible in a fit patient with good respiratory reserve and cardiac function and a tumor that has not invaded significantly beyond the parietal pleura. It is sometimes necessary to resect the diaphragm and replace it with a macron mesh.

Clearly, these limitations mean that the patients are highly selected and so, even in areas where the tumor is a very frequent, experience of the procedure will be quite limited. It is therefore assess its true value, particularly as it is associated with significant morbidity.

The second procedure is pleural stripping. Again the patients who are suitable for this treatment are those with caused disease and no significant partial pleural involvement, and it is therefore probably only appropriate for those who present with recurrent pleural effusion rather than chest wall pain. It is a less morbid procedure and its advocates claiming it as an effective way of controlling the problem of effusion but it is not clear whether it also confers any survival benefit.



Radiotherapy for Mesothelioma

It is widely believed that Mesothelioma is not at all responsive to radiotherapy. This is not entirely true. Certainly with most sarcomas, a high dose is probably needed to achieve any durable tumor control, but useful responses can be seen even with relatively low, palliative doses.
The typical presentation and pattern of spread over the pleural surface means that high dose, radical radiotherapy is technically difficult, because the volume has to be very large and may include substantial amounts of normal tissues such as lung heart and liver, that cannot tolerate the high dose needed. Techniques using combinations of megavoltage X-rays and electron seeds have been described, but they are inevitably complex and it is not clear whether they actually effective. Certainly there may be patients with a small volume of disease for whom radical radiotherapy might be an option but, as with surgery until techniques for early diagnosis improve they will remain extremely uncommon.

Radiotherapy does have a limited but useful role in the palliation of patients with Mesothelioma. Wide-field radiotherapy including the whole hemi thorax from midline to lateral chest wall can be given to a does of 30 gy in then fractions and provide reasonable,
If short-lived, improvement in pain, It is necessary to treat a wide field because of the characteristic spread of the tumor and the poorly localized, diffuse nature of the pain.

This treatment is usually well tolerated. Nausea and vomiting may occur, especially if the diaphragm is included in the field and a significant amount of liver or stomach is irradiated. Treating a large volume of the lung to this dose is not really a problem even though it is higher than lung tolerance, because few patients survive long enough to get pneumonitis and anyway, if the tumor is widespread, the lung is effectively splinted and non-functional.

Palliative radiotherapy can also be useful in treating patients with troublesome masses growing through the chest wall especially down the tracks of biopsy needles and chest drains. These lumps can be painful, car fumigate and bleed, or when large enough can be physically awkward for the patient usually a direct field to cover the mass can be used, but sometimes a pair of opposed glancing fields may be needed for a very large mass. A small area in an unfit patient could be a adequately treated with a single fraction of 10-15Gy, but higher doses such as 30Gy in 10 fractions or 40Gy in 15 fractions may be moiré appropriate if a large volume is treated or a more durable response is needed in a fitter patient.

Radiotherapy can also be used to prevent tumor seeding down the needle tracks. This occurs in about a third of patients who have had needle biopsies or repeated pleural drainage and for some it can be unpleasant and troublesome. A dose of 21 Gy in three daily fractions using orthovoltage X-rays or electrons and covering the area of the needle track of biopsy site may reduce the incidence of this problem.



Chemotherapy of Mesothelioma

Malignant Mesothelioma is a decreasingly difficult tumor to treat. Because of the usual delays in presentation and diagnosis it is very unusual for any potentially curative procedure to be opossible. Managem it is therefore prinmarily aimed at palliation and symptom control.

The chest X-ray typically shows basal homogeneous pacifications on one side due to pleural fluid and sometimes there is evidence of pleural thickening extending upwards around the lung edge. With more advanced disease, ovulated pleural shadowing may appear and, as the tumor progresses and encases the lung, there may be gradual loss of volume on the affected side. Calcified pleural plaques may be present indicating previous asbestos exposure.
CT scanning is very useful in evaluating a patient with suspected Mesothelioma. The appearances may be very characteristic, with an extensive area of pleural tumor encasing the lung and often with an associated pleural effusion.
Although the chest X-ray and CT appearances can strongly suggest the diagnosis of Mesothelioma, it is important to attempt to confirm the diagnosis histologicaly.
Pleural aspiration and biopsy.
A patient suspected of having Mesothelioma will usually have a significant pleural effusion at presentation. The first investigation after a chest X-ray should therefore be pleural aspiration. Pleural aspiration is performed simply under local anesthesia. If there is doubt about the size or location of the pleural fluid, a brief ultrasound examination of the chest may help localize the best site for aspiration.
The fluid obtained is typically a blood-stained exudates. Unfortunately, cytological examination confirms the diagnosis in fewer than 50% of cases. This is partly because it can be difficult to distinguish between reactive mesothelial cells and malignant cells and even if malignant cells are seen, it may be difficult to decide whether they come from a primary or secondary pleural tumor.
If pleural aspiration does not give the diagnosis pleural biopsy, using an Abraham needle, should be carried out. The diagnostic yield is probably no greater than 60% but it may give a more positive diagnosis than cytology. Cutting-needle or incision biopsy of a pleural mass identified on CT scan or of a palpable chest-wall tumor gives the best chance of a definite diagnosis.
Following pleural aspiration or biopsy up to a third of patients will develop tumor seeding down the needle track. Radiotherapy may be helpful in preventing this problem.

Thoracoscopy

If a clear diagnosis is not obtained by pleural aspiration and biopsy, thoracoscopy should be considered. With the advent of flexible fiber optic thoracoscopes, it is possible to carry this out under sedation and local anesthesia rather than putting the patient through a general anesthetic. It may be possible to biopsy pleural nodules and masses under direct vision. Patients should not be subjected to thoracotomy unless there is a real possibility of a successful resection.
Any patient with a persistent undiagnosed pleural effusion, particularly if there is a history of asbestos exposure should have a thoracoscopy to establish the diagnosis. This may be the only way of increasing the number of patients diagnosed early in the course of their illness.

Cough
Shortness of breath,
Difficulty breathing
pleural effusions (fluid in the chest cavity)
pain in the chest and abdominal regions
loss of appetite and weight loss

This tumor most commonly occurs in middle-aged or elderly men with an occupational history of asbestos exposure. The early symptoms are often minor and slowly progressive; this often results in the patients presenting late. The median time from the first symptom to presentation is around six months.

The two commonest presenting symptoms are chest pain and dyspnoea. The chest pain usually starts as a vague ache on the affected side which gradually becomes more severe but is often rather diffuse and poorly localized and uncommonly associated with local tenderness. The increasing breathlessness is usually due to a pleural effusion rather than pulmonary constriction, at least in the early stages. Other common symptoms are cough tiredness, anorexia and weight loss.
The commonest clinical finding at presentation is a pleural effusion and, as the tumor progresses, then it is the evidence of marked loss of lung volume on the affected side. Sometime commonly if thoracoscopy or repeated inter-costal tube drainage has been used for small nodules or a larger mass may be felt in the chest wall.

These are classified as primary and secondary. Primary pleural tumors are mostly mesotheliomas, of which localized benign and diffuse and malignant types are recognized. In both types, fibrous or fibrosar-comatous and epithelioid varieties are seen.
Mixtures of the two histological varieties also occur. Therefore the pathologic classification of easily removable tumor ordinarily arises from the visceral pleura. When it is excised, the symptoms and signs of arthralgia and pulmonary ostearthropathy disappear and longevity seems to be unaffected. These tumors may range in size from a few centimeters to 20 cm or more in diameter.
Diffuse or malignant mesotheliomas, on the other hand, cause chest pain and bloody pleural effusion containing malignant mesothelial cells. These tumors are characterized by findings ranging from multiple papillary projections on both visceral and parietal pleurae to encasement of the entire lung in a thick ring of tumor, with similar findings on the parietal side. Part or all of the pleural space may be obliterated. Metastases are uncommon, except late in the disease, and are often limited to the regional lymph nodes. Extrahoracic metastases do occur. However. Death within 1 or 2 years is the rule in the majority of cases.

The evidence for a causal relationship between exposure to asbestos dust and the development of malignant Mesothelioma is strong. It is based on occupational exposure, with a high incidence of both pleural Mesothelioma and bronchogenic carcinoma in asbestos workers and those exposed to asbestos.
Treatment of malignant Mesothelioma has been unsatisfactory. There have been no cures. Palliation, and a small number of 4-to 7-year survivals have been achieved by "complete" pleurectomy or pleuropneu-monectomy, but the great majority of patients have succumbed within 1 or 2 years of the diagnosis regardless of the type of treatment used. Radiation and chemotherapy or combined treatment is recommended if excision surgery is impossible or incomplete. However none of these treatment modalities has been fully studied in a systematic way"

Pleural involvement by metastatic disease is for more common than primary pleural tumor and is usually associated with implants involving the lung or with blockage of or interference with the lymphatic drainage of the visceral, parietal, diaphragmatic, or mediastinal pleura. The most common sites of primary tumor are the lung, breast , pancreas, and stomach. With direct involvement of the pleura by tumor implants, bloody fluid containing neoplastic cells can often be obtained. Various types of palliative treatment are advocated, depending upon the site of the primary tumor, the expansibility of the lung, the degree of disability from pleural effusion, and so forth. Hormonal therapy, radiation or radioisotope therapy, multiple aspirations of the chest, closed-tube thoracostomy, and the insufflations of talc or the instillation of chemotherapeutic agents (especially quinacrine and tetracycline ) have all been reported with varying degrees of palliation being achieved. Pleurectomy is the most effective, but mortality (10 per cent ) and morbidity 20 per cent ) dictate careful patient selection.

The asbestos fibers are inhaled and, being sharp and straight, penetrate directly through the lung to the visceral pleura. The actual mechanism where by these fibers induce malignant change remains unclear.

When the pleural tumor develops it is often associated with a pleural effusion. As the malignant process advances, the lung is gradually encased in a thick rim of tumor and there may be direct tumor extension into the chest wall, Pericardium, contra-lateral pleura and, more rarely, through the diaphragm into the abdominal cavity.

Systemic metastases are more frequent than was once thought and the incidence of metastases at post mortem ranges from 30 to 80% in different series. However they seem to occur late in the course of the illness and are not often symptomatic. It is usually the local effects of the tumor that eventually cause death. The commonest sites of metastasis are lymph nodes, lung and liver, while bone and brain metastates are less common.

Asbestos mining and processing
Shipyard workers
Boilermakers
Power station builders
Central heating and ventilation engineers
Refrigeration engineers
Builders
Railway coach builders
Demolition workers
Joiners


Mesothelioma has also been reported in relatives of asbestos workers who may have been exposed to fibers by laundering working clothes and also people who lived near asbestos manufacturing plants as children and were exposed to the dust.

There are currently over 700 deaths per year from Mesothelioma in the United kingdom and the incidence will probably continue to rise well into the next century because of the increasing use of asbestos without protection until 1970

It has been known for 30 years that malignant Mesothelioma is usually associated with exposure to asbestos, although in 10% of cases there may be no clear history of occupational or environmental exposure. It is very important to take a careful occupational history as this may affect the patient ability to obtain compensation. Asbestos was widely used in a number of industrial and manufacturing process and as a building material and adequate controls over its use were not in place in the United kingdom until 1970s. The occupations most often associated with asbestos exposure and Mesothelioma. There may be a very long interval, up to fifty years between the known exposure and the development of the tumor.

Asbestos has different crystalline forms but it appears that amphiboles with linear fibers, particularly crocidolite Cause Mesothelioma.

Any malignant growth or tumor caused by abnormal and uncontrolled cell division; it may spread to other parts of the body through the lymphatic system or the blood stream.

The basic structural and functional unit of all organisms; cells may exist as independent units of life (as in monads) or may form colonies or tissues as in higher plants and animals.

Mesothelioma ( cancer of the mesothelium) is a disease in which cells of the mesothelium become abnormal and devide without control or order. They can invade and damage nearby tissues or organs. Cancer cells also spread from their original site to other part of the body. Most cases of mesothelioma begin in the pleura or peritoneum.

Tissue formed by specialized cells lining the chest, abdominal cavities and outer surface of most internal organs. The mesothelium produces a lubricating fluid that helps organs by enabling them to move. Such as beating hearts and contracting lungs.